Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 4/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 3/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2445110 | 0.88 | ALDH1A1 (0.48) | ALDH1A1HPGDTP53CES2CES1 | |
| SCHEMBL2939540 | 0.88 | ALDH1A1 (0.39) | ALDH1A1HPGDTP53CES2CES1 | |
| SCHEMBL26486703 | 0.86 | FAAH (0.41) | ALDH1A1CES2CES1FAAHTSHR | |
| SCHEMBL2445366 | 0.86 | FAAH (0.44) | ALDH1A1CES2CES1FAAHTSHR | |
| SCHEMBL2447083 | 0.84 | ALDH1A1 (0.37) | ALDH1A1TP53CES2CES1HDAC3 | |
| SCHEMBL1358419 | 0.84 | ALDH1A1 (0.37) | ALDH1A1HPGDTP53CA12CA2 | |
| SCHEMBL2441774 | 0.84 | FAAH (0.47) | ALDH1A1CES2CES1FAAHTSHR | |
| SCHEMBL2447538 | 0.84 | FAAH (0.47) | ALDH1A1CES2CES1FAAHTSHR | |
| SCHEMBL2442886 | 0.84 | FAAH (0.47) | ALDH1A1CES2CES1FAAHTSHR | |
| SCHEMBL2447450 | 0.84 | FAAH (0.47) | ALDH1A1CES2CES1FAAHTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10551345-B2 | Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS, LLC (US) | 2020-02-04 | — | — | US | claimed |
| US-20170356877-A1 | POLY AND COPOLY(N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS, LLC (US) | 2017-12-14 | — | — | US | claimed |
| US-9671367-B2 | Poly and copoly(N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS, LLC (US) | 2017-06-06 | — | — | US | claimed |
| US-20140209461-A1 | Poly and Copoly(N-vinylamide)s and Their Use In Capillary Electrophoresis | APPLIED BIOSYSTEMS, LLC (US) | 2014-07-31 | — | — | US | claimed |
| EP-2053067-B1 | Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS LLC (US) | 2011-09-14 | — | — | EP | claimed |
| CN-101724216-A | Poly and copolyn(N-vinylamide)s and their use in capillary electrophoresis | APPLIED BIOSYSTEMS | 2010-06-09 | — | — | CN | claimed |
| US-20100051461-A1 | Poly and Copolyn(N-Vinylamide)s and their use in Capillary Electrophoresis | Life Technologies Corporation (US) | 2010-03-04 | — | — | US | claimed |
| CN-100567339-C | (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis | APPLERA CORP (US) | 2009-12-09 | — | — | CN | claimed |
| EP-2053067-A1 | Poly and copoly (N-vinylamide)s and their use in capillary electrophoresis | Applied Biosystems Inc. (US) | 2009-04-29 | — | — | EP | claimed |
| EP-1636279-B1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLIED BIOSYSTEMS (US) | 2009-02-18 | — | — | EP | claimed |
| CN-1816573-A | (N-vinylamide) polymers and copolymers and their use in capillary electrophoresis | APPLERA CORP (US) | 2006-08-09 | — | — | CN | claimed |
| EP-1636279-A1 | POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | Applera Corporation (US) | 2006-03-22 | — | — | EP | claimed |
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | APPLIED BIOSYSTEMS, LLC | 2005-02-03 | — | — | US | claimed |
| WO-2004104054-A1 | POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS | APPLERA CORPORATION (US) | 2004-12-02 | — | — | WO | claimed |
| CN-117986814-A | Antibacterial biodegradable expanded beads, preparation method thereof, expanded bead molded body and application thereof | 中国石油化工股份有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117946489-A | Composite antibacterial agent, blown film, preparation method and application thereof, antibacterial biodegradable polyester composition, polyester material and preparation method | 中国石油化工股份有限公司 | 2024-04-30 | — | — | CN | disclosed |
| US-20240118238-A1 | COMPOSITIONS AND KITS COMPRISING INTERPENETRATING POLYMER NETWORK FOR CAPILLARY ELECTROPHORESIS | HONGENE BIOTECH CORPORATION | 2024-04-11 | — | — | US | disclosed |
| US-5965651-A | CONTAINING A CROSSLINKING AGENT, N-VINYLCARBOXAMIDE COPOLYMER HAVING A FUNCTIONAL GROUP CAPABLE OF CROSSLINKING WITH CROSSLINKER, WATER, WATER SOLUBLE ORGANIC SOLVENT, AND PLASTICIZER; MOLDED INTO FILMS, SHEETS, POWDER AND FLAKES | SHOWA DENKO K.K. (JP) | 1999-10-12 | — | — | US | disclosed |
| EP-0844006-A1 | Liquid-absorbing material composition, molded product therefrom, process for preparing the same and use thereof | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1998-05-27 | — | — | EP | disclosed |
| US-4179292-A | Light-sensitive copying composition | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050025741-A1 | Copolymers with (meth)acrylamides; improved separation of polynucleotides | POLI, PCNA, POLL | ALDH1A1 3357/4885HPGD 2263/4885TP53 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.